COMPANY PROFILE

Myocor

Explore full profile

A Minneapolis-based medical device company

Maple Grove, United StatesFounded 1996Health Tech & Medtech

Valuation $100–250M Last recorded · 2004

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Myocor

Myocor is a medical technology company focused on developing innovative therapeutic devices to optimize treatment options for patients suffering from diseases associated with geometrically remodeled hearts. The company's proprietary Shape Change Therapy is at the core of its product development, aiming to restore cardiac function by altering the geometry of the heart. Myocor primarily serves patients with cardiovascular diseases, particularly those who have experienced myocardial infarction or other heart-related conditions. Operating in the medical device market, Myocor's business model revolves around the research, development, and commercialization of its therapeutic devices. Revenue is generated through the sale of these devices to healthcare providers and institutions. The company also invests in ongoing clinical research to validate the efficacy of its products and expand its market reach.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 1996
Headquarters: Maple Grove, United States
Open positions: None listed
Dealroom signal: 18.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, medical implants, Surgery, Cardiology and cardiovascular, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Oct 2008	$0	—	Edwards Lifesciences	—
SERIES D✓Equity / VC	Dec 2004	$24M	$96M	Prism Venture Management	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Myocor website traffic

Latest recorded traffic for Myocor is 140 monthly website visits, down 12.5% over the last three months.

Latest monthly visits140 3-month web change-12.5%

Monthly website visitsOct 2017–Jan 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
APApproximaThe first minimally invasive treatment tailored for the tricuspid valve	Milan, Italy	Operational	18	$19M	$39M
MVMVRxA transcatheter annular reduction therapy system that is designed to improve heart function for those with congestive heart failure	San Carlos, United States	Operational
PMPulse MedicalCardiovascular interventional medical device research and development producer	Zhuhai, China	Operational
AMAtaCor MedicalDesigning innovative solutions for cardiac rhythm management, including the AtaCor EV Temporary Pacing Lead System	San Clemente, United States	Operational
HYHylomorphHylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implantable medical devices and tissues	Zurich, Switzerland	Operational
IMInnAVasc MedicalProducts for vascular access for hemodialysis	Durham, United States	Acquired
ATArbor Surgical TechnologiesArbor Surgical Technologies a cardiovascular medical device company focuses on heart valve replacement market	Irvine, United States	Operational
EMEssential MedicalDevelop and commercialize new vascular closure devices for femoral punctures after diagnostic and interventional cardiac catheterization procedures	West Whiteland Township, United States	Acquired